TY - JOUR
T1 - Differential distribution of insulin-like growth factor-1 and insulin-like growth factor binding proteins in experimental diabetic rat kidney
AU - Miyatake, Nobuyuki
AU - Shikata, Kenichi
AU - Wada, Jun
AU - Sugimoto, Hikaru
AU - Takahashi, Shin Ichiro
AU - Makino, Hirofumi
PY - 1999
Y1 - 1999
N2 - Insulin-like growth factor-1 (IGF-1) is a peptide growth factor, and its activity is modulated by interaction with the family of IGF binding proteins (IGFBP-1 to 6). IGF-1 is detected in rat kidney and has metabolic and growth effects. To explore the possible involvement of IGFBPs in glomerular hypertrophy in streptozotocin (STZ)-induced diabetic rat, the immunolocalization of IGF-1 and IGFBPs were investigated. IGF-1 was gradually increased in the glomeruli of diabetic rats and correlated with glomerular hypertrophy. IGFBP-1 was transiently increased at 1 week after the STZ injection and declined to control level during the following period. In contrast, IGFBP-4 was increased in the diabetic glomeruli throughout the observation period. With insulin treatment, the levels of IGF-1, IGFBP-1 and 4 were normalized and glomerular hypertrophy was prevented. Initial glomerular hypertrophy of diabetic nephropathy is a related IGF-1 action, which may be modulated by IGFBP-1 and 4.
AB - Insulin-like growth factor-1 (IGF-1) is a peptide growth factor, and its activity is modulated by interaction with the family of IGF binding proteins (IGFBP-1 to 6). IGF-1 is detected in rat kidney and has metabolic and growth effects. To explore the possible involvement of IGFBPs in glomerular hypertrophy in streptozotocin (STZ)-induced diabetic rat, the immunolocalization of IGF-1 and IGFBPs were investigated. IGF-1 was gradually increased in the glomeruli of diabetic rats and correlated with glomerular hypertrophy. IGFBP-1 was transiently increased at 1 week after the STZ injection and declined to control level during the following period. In contrast, IGFBP-4 was increased in the diabetic glomeruli throughout the observation period. With insulin treatment, the levels of IGF-1, IGFBP-1 and 4 were normalized and glomerular hypertrophy was prevented. Initial glomerular hypertrophy of diabetic nephropathy is a related IGF-1 action, which may be modulated by IGFBP-1 and 4.
KW - Diabetic rat
KW - Glomerular hypertrophy
KW - Insulin-like growth factor binding proteins
KW - Insulin-like growth factor-1
KW - Streptozotocin
UR - http://www.scopus.com/inward/record.url?scp=0033033441&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033033441&partnerID=8YFLogxK
U2 - 10.1159/000045299
DO - 10.1159/000045299
M3 - Article
C2 - 10050087
AN - SCOPUS:0033033441
SN - 0028-2766
VL - 81
SP - 317
EP - 323
JO - Nephron
JF - Nephron
IS - 3
ER -